Immatics N.V. (IMTX) Social Stream



Immatics N.V. (IMTX): $12.58

0.43 (-3.31%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add IMTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#69 of 348

in industry

IMMATICS NV (IMTX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IMTX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-18 4 $30 $19 $24.25 $12.17 99.26%
2022-03-23 4 $32 $19 $25.25 $12.17 107.48%
2022-03-24 4 $30 $20 $23.75 $12.17 95.15%
2022-06-02 4 $30 $14 $22.25 $12.17 82.83%
2022-06-07 4 $30 $14 $22.5 $12.17 84.88%
2022-07-14 4 $30 $14 $20.25 $12.17 66.39%
2022-08-10 4 $28 $16 $20.25 $12.17 66.39%
2023-02-08 4 $28.9 $16 $20.475 $12.17 68.24%
2023-03-21 4 $28.9 $16 $20.225 $12.17 66.19%
2023-03-24 3 $25 $16 $19.25 $12.17 58.18%
2023-04-05 4 $25 $12 $17.8 $12.17 46.26%
2023-08-17 5 $25 $12 $17.8 $12.17 46.26%
2023-08-18 5 $25 $14 $18.4 $12.17 51.19%
2023-09-18 5 $25 $14 $18.8 $12.17 54.48%
2023-11-15 6 $25 $14 $19.6 $12.17 61.05%

The Trend in the Analyst Price Target


Over the past 27 months, IMTX's average price target has gone down $4.68.

Over the past 42 weeks, IMTX's average upside potential has been 116.58%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-26 4 28.9 16 20.475 7.81 162.16%
2023-02-08 4 28.9 16 20.475 8.58 138.64%
2023-05-02 5 25.0 12 17.800 9.33 90.78%
2023-08-17 5 25.0 12 17.800 11.60 53.45%
2023-11-15 6 25.0 14 18.800 8.93 110.53%

IMTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


Over the past 25 months, IMTX's average broker recommendation rating improved by 0.2.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • IMMATICS NV's number of analysts covering the stock is higher than 270.5% of all US stocks.
  • In the context of all US stocks, IMMATICS NV's average analyst price target is higher than 435.85% of them.
  • IMTX has a greater upside potential (average analyst target price relative to current price) than 1242.63% of all US stocks.
  • IMTX has a lower variance in analysts' estimates than -1003.04% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to IMMATICS NV are STRO, CLLS, and ADAP.

Make investment decisions regarding IMTX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!